HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lixisenatide in Type 2 Diabetes and Acute Coronary Syndrome.

AuthorsGiuseppe Derosa, Pamela Maffioli
JournalThe New England journal of medicine (N Engl J Med) Vol. 374 Issue 11 Pg. 1095 (03 17 2016) ISSN: 1533-4406 [Electronic] United States
PMID26981947 (Publication Type: Letter, Comment)
Chemical References
  • Dipeptidyl-Peptidase IV Inhibitors
  • Glucagon-Like Peptide-1 Receptor
  • Hypoglycemic Agents
  • Peptides
  • Piperidines
  • Uracil
Topics
  • Acute Coronary Syndrome (drug therapy)
  • Angina, Unstable (drug therapy)
  • Diabetes Mellitus, Type 2 (drug therapy)
  • Dipeptidyl-Peptidase IV Inhibitors (therapeutic use)
  • Female
  • Glucagon-Like Peptide-1 Receptor (agonists)
  • Humans
  • Hypoglycemic Agents (therapeutic use)
  • Male
  • Myocardial Infarction (drug therapy)
  • Peptides (therapeutic use)
  • Piperidines (therapeutic use)
  • Uracil (analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: